Self‐Assembled Aptamer‐Derived PROTAC Enables Efficient Cellular Internalization for Intracellular Sclerostin Degradation and Triple‐Negative Breast Cancer Therapy

Hang Luo, Zefeng Chen, Yufei Pan, Meiheng Sun, Yihao Zhang, Huarui Zhang, Hewen Jiang, Xiaohui Tao, Yingchao Wu, Kuikun Yang, Xin Yang, Shijian Ding, Luyao Wang, Yuanyuan Yu, Zhiyu Wang, Yixin He, Qianjun Chen, Sifan Yu, Yuan Ma, Baoting Zhang, Ge Zhang

Open source

DOI: 10.1002/adhm.71723
Published: 2026-09-13
Container: Advanced Healthcare Materials
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/adhm.71723,
  title = {Self‐Assembled Aptamer‐Derived PROTAC Enables Efficient Cellular Internalization for Intracellular Sclerostin Degradation and Triple‐Negative Breast Cancer Therapy},
  author = {Hang Luo and Zefeng Chen and Yufei Pan and Meiheng Sun and Yihao Zhang and Huarui Zhang and Hewen Jiang and Xiaohui Tao and Yingchao Wu and Kuikun Yang and Xin Yang and Shijian Ding and Luyao Wang and Yuanyuan Yu and Zhiyu Wang and Yixin He and Qianjun Chen and Sifan Yu and Yuan Ma and Baoting Zhang and Ge Zhang},
  year = {2026},
  journal = {Advanced Healthcare Materials},
  doi = {10.1002/adhm.71723},
  url = {https://doi.org/10.1002/adhm.71723}
}

RIS

TY  - JOUR
TI  - Self‐Assembled Aptamer‐Derived PROTAC Enables Efficient Cellular Internalization for Intracellular Sclerostin Degradation and Triple‐Negative Breast Cancer Therapy
AU  - Hang Luo
AU  - Zefeng Chen
AU  - Yufei Pan
AU  - Meiheng Sun
AU  - Yihao Zhang
AU  - Huarui Zhang
AU  - Hewen Jiang
AU  - Xiaohui Tao
AU  - Yingchao Wu
AU  - Kuikun Yang
AU  - Xin Yang
AU  - Shijian Ding
AU  - Luyao Wang
AU  - Yuanyuan Yu
AU  - Zhiyu Wang
AU  - Yixin He
AU  - Qianjun Chen
AU  - Sifan Yu
AU  - Yuan Ma
AU  - Baoting Zhang
AU  - Ge Zhang
PY  - 2026
JO  - Advanced Healthcare Materials
DO  - 10.1002/adhm.71723
UR  - https://doi.org/10.1002/adhm.71723
ER  -

APA

Luo, H., Chen, Z., Pan, Y., Sun, M., Zhang, Y., Zhang, H., Jiang, H., Tao, X., Wu, Y., Yang, K., Yang, X., Ding, S., Wang, L., Yu, Y., Wang, Z., He, Y., Chen, Q., Yu, S., Ma, Y., Zhang, B., & Zhang, G. (2026). Self‐Assembled Aptamer‐Derived PROTAC Enables Efficient Cellular Internalization for Intracellular Sclerostin Degradation and Triple‐Negative Breast Cancer Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71723

Source records

crossref · retrieved 2026-09-25T20:21:48.568Z